SYSTEMATIC FINANCIAL MANAGEMENT LP
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1085936
TEANECK, NJ
Position in SUPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,051,832
+$2,612,310 QoQ
Shares Held
474,131
+26.1% QoQ
Ownership
0.816%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#28
of 331 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SYSTEMATIC FINANCIAL MANAGEMENT LP holds $42,907,500 across 3 Drug Manufacturers - Specialty & Generic names. SUPN ranks #1 (51.4% of the industry book) .
All Filings in SUPN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,051,832 | 474,131 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $19,439,522 | 376,079 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $15,120,031 | 304,226 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $13,967,105 | 292,260 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $7,739,578 | 245,545 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $5,453,006 | 166,504 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $4,104,160 | 113,500 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $878,808 | 28,185 | Shares | Defined | 2024-11-14 | |
| 2020-06-30 | $335,112 | 14,110 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $388,224 | 21,580 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||